Skip to content

Half-normal Saline in Atrial Flutter Ablation

Verification of Half Normal Saline as a Superior Irrigant in the Catheter Radiofrequency Ablation of Typical Cavotricuspid Isthmus Dependent Atrial Flutter: A Multicenter Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04001530
Enrollment
4
Registered
2019-06-28
Start date
2018-01-01
Completion date
2021-01-31
Last updated
2021-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Flutter

Brief summary

To assess the acute and long-term efficacy of half-normal saline compared to normal saline for irrigation of open-irrigated catheters during catheter ablation for the treatment of cavotricuspid isthmus dependent atrial flutter.

Detailed description

It is unclear whether ionic strength affects energy delivery and ablation lesion size during radiofrequency ablation for atrial flutter. Given that saline contains ionic sodium and chloride in the solution, it has conductive properties that may disperse radiofrequency energy away from the tip-tissue interface, thereby reducing current density and lesion size compared to ablation with nonionic solutions. The efficacy of half-normal saline will be measured by the time taken to create bidirectional block across the cavotricuspid isthmus as well as the acute recurrence rate within 30 minutes of the initial occurrence of bidirectional block and the 1 year freedom from flutter recurrence.

Interventions

DRUGHalf Normal Saline 0.45% Infusion Solution Bag

Randomization to half normal saline

Randomization to normal saline

Sponsors

Sunnybrook Health Sciences Centre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients \> 18 years of age at the time of enrollment * Patients presenting for right sided typical atrial flutter ablation who have a clinical indication to undergo catheter ablation * Fully informed written informed consent by either the subject or subject's legal representative and ability for subject to comply with study responsibilities

Exclusion criteria

* The presence of thrombus within the left atrial appendage * Prior catheter ablation of the cavotricuspid isthmus for right sided atrial flutter * The inability to provide consent or comply with study requirements * A predicted life expectancy of \< 12 months

Design outcomes

Primary

MeasureTime frame
Acute recurrence rate < 30 minutes of initial occurrence of bidirectional blockintraprocedural
Time taken to produce bidirectional blockintraprocedural
Freedom from atrial flutter recurrence1 year

Secondary

MeasureTime frame
Total radiofrequency ablation time and procedural timeintraprocedural
Time taken for termination of atrial flutterintraprocedural

Other

MeasureTime frameDescription
Incidence of procedure-related complicationsat the time of the procedure and up to 1 monthpericardial effusion due to cardiac perforation or pericarditis, transient ischemic attack/stroke, systemic embolism, phrenic nerve injury, pulmonary vein stenosis, atrio-esophageal fistula, death
Incidence of steam popsperiproceduralmarker of excessive heating of the tissue

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026